Crossmark

Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study

Crossref DOI link: https://doi.org/10.1186/s13075-018-1544-9

Published Online: 2018-03-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bluett, James

Sergeant, Jamie C.

MacGregor, Alex J.

Chipping, Jacqueline R.

Marshall, Tarnya

Symmons, Deborah P. M.

Verstappen, Suzanne M. M.
Funding

Funding for this research was provided by:

Medical Research Council (G1000417/94909)

Arthritis Research UK (20380, 20385)
License Information

Text and Data Mining valid from 2018-03-20
More Information

Article History

Received: 20 April 2017

Accepted: 18 February 2018

First Online: 20 March 2018

Ethics approval and consent to participate

: All participants provided informed consent and the study was approved by the East of England - Cambridgeshire and Hertfordshire Research Ethics Committee (REC:15/EE/0076).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.